NCT05047809 is a NA clinical trial of "Jingchuang Ointment"(JCO) in Leprosy, sponsored by Lo-Sheng Sanatorium.

Who is sponsoring NCT05047809?

NCT05047809 is sponsored by Lo-Sheng Sanatorium.

What drugs are being tested in NCT05047809?

Interventions in NCT05047809: "Jingchuang Ointment"(JCO), Regular Treatment.

What condition does NCT05047809 study?

NCT05047809 studies Leprosy, Hansen's Disease, Wounds.

Is NCT05047809 still recruiting?

NCT05047809 is currently completed. Last updated 13 March 2024.

Last reviewed 2024-03-13 · How we verify

NCT05047809

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of "Jinchuang Ointment" (JCO) on the Treatment of Wounds in Patients With Hansen's Disease.

Completed NA Last updated 13 March 2024

What this trial tests

NA trial testing "Jingchuang Ointment"(JCO) in Leprosy in 20 participants. Completed in 5 May 2022.

Timeline

7 August 2021

Primary endpoint
5 September 2021

5 May 2022

Quick facts

Lead sponsor	Lo-Sheng Sanatorium
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	7 August 2021
Primary completion	5 September 2021
Estimated completion	5 May 2022
Sites	1 location across Taiwan

Drugs / interventions tested

"Jingchuang Ointment"(JCO)
Regular Treatment — full drug profile →

Conditions studied

Leprosy — all drugs for Leprosy →
Hansen's Disease — all drugs for Hansen's Disease →
Wounds — all drugs for Wounds →

Sponsor

Lo-Sheng Sanatorium

Who can join

Adults 20 to 85, any sex, with Leprosy or Hansen's Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to evaluate the effect of a Chinese herb complex "Jinchuang ointment" (JCO) on the treatment of chronic nonhealing wounds in patients with Hansen's disease and its mechanism.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Leprosy

Currently open trials in the same condition.

NCT07515989 — Accuracy of the Polymerase Chain Reaction of Ulnar Perineural Subcutaneous Aspirate Guided by Ultrasound for the Diagnos · NA · recruiting
NCT06761469 — Leprosy Active Searching Trial in Brazil · NA · recruiting
NCT06819449 — Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients · NA · recruiting
NCT06683690 — TGF β 1 Expression Related Gene Polymorphism · recruiting
NCT05597280 — Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy · Phase 3 · recruiting

Other Lo-Sheng Sanatorium trials

Trials by the same sponsor.

NCT05091216 — The Effects of Traditional Chinese Medicine Mouthwash Solutions on the Oral Health of Leprosy Patients · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05047809 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lo-Sheng Sanatorium
Last refreshed: 13 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05047809.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing